These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22564052)

  • 21. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
    Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
    Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
    du Plessis LH; Lubbe J; Strauss T; Kotzé AF
    Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
    Umerska A; Corrigan OI; Tajber L
    Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
    Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement.
    Trier S; Linderoth L; Bjerregaard S; Strauss HM; Rahbek UL; Andresen TL
    Eur J Pharm Biopharm; 2015 Oct; 96():329-37. PubMed ID: 26347924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes.
    Manosroi A; Khanrin P; Lohcharoenkal W; Werner RG; Götz F; Manosroi W; Manosroi J
    Int J Pharm; 2010 Jun; 392(1-2):304-10. PubMed ID: 20381599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lyophilization on liposomal encapsulation of salmon calcitonin.
    Swaminathan J; Ehrhardt C
    J Liposome Res; 2014 Dec; 24(4):297-303. PubMed ID: 24708057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions.
    Fan Y; Li X; Zhou Y; Fan C; Wang X; Huang Y; Liu Y
    Int J Pharm; 2011 Sep; 416(1):323-30. PubMed ID: 21726618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
    Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
    J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine.
    Chen C; You P
    Drug Des Devel Ther; 2017; 11():1941-1949. PubMed ID: 28721013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of the skin penetration of protein transduction domains and a conjugated peptide.
    Lopes LB; Brophy CM; Furnish E; Flynn CR; Sparks O; Komalavilas P; Joshi L; Panitch A; Bentley MV
    Pharm Res; 2005 May; 22(5):750-7. PubMed ID: 15906170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics.
    Zhang L; Li Y; Wei F; Liu H; Wang Y; Zhao W; Dong Z; Ma T; Wang Q
    AAPS PharmSciTech; 2020 Nov; 22(1):1. PubMed ID: 33215299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy.
    Li Y; Ju XJ; Fu H; Zhou CH; Gao Y; Wang J; Xie R; Wang W; Liu Z; Chu LY
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):638-650. PubMed ID: 36576723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.
    Karsdal MA; Byrjalsen I; Riis BJ; Christiansen C
    BMC Clin Pharmacol; 2008 Sep; 8():5. PubMed ID: 18782439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery.
    Chen M; Li XR; Zhou YX; Yang KW; Chen XW; Deng Q; Liu Y; Ren LJ
    Peptides; 2009 Jul; 30(7):1288-95. PubMed ID: 19540427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery.
    Lee HE; Lee MJ; Park CR; Kim AY; Chun KH; Hwang HJ; Oh DH; Jeon SO; Kang JS; Jung TS; Choi GJ; Lee S
    J Control Release; 2010 Apr; 143(2):251-7. PubMed ID: 20026364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis.
    Liu Y; Yu P; Peng X; Huang Q; Ding M; Chen Y; Jin R; Xie J; Zhao C; Li J
    J Control Release; 2019 Jun; 304():39-50. PubMed ID: 31054990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.